DRUGSwww.epgonline.orgDISEASE KNOWLEDGE CENTRESwww.epgonline.orgGUIDELINESwww.epgonline.orgCLINICAL TRIALSwww.epgonline.orgMEDICAL NEWSwww.epgonline.orgLINKSwww.epgonline.org
Members Login
How to use the
Email

Password



EPG News Feed Medical News
EPG Online Disease Knowledge Centres Feed Disease Knowledge
Recent UK Drug Updates Drug Updates
EPG Search
Frequent Searches:
Search
Languages

Medical News Headlines
Expert praises Parkinson's treatment
The treatment of Parkinson's disease with levodopa has been discussed...
Published Thursday 04 December 2008

Annual report finds cancer initiative a success
A new initiative that aims to improve the treatment of...
Published Thursday 04 December 2008

New game could help tackle obesity and diabetes in kids, expert claims
A new scheme from the British Heart Foundation (BHF) will...
Published Thursday 04 December 2008

Some "good cholesterol" not good enough, study suggests
A number of preconceptions about "good" HDL cholesterol have been...
Published Tuesday 02 December 2008

More Medical News
Browse Other Languages
Alzheimer's disease (AD) is a progressive, neurodegenerative disease which will affect most of us at one point in time, and it’s prevalence increases with age. The prognosis of patients with diabetes is improved by interventions that reduce HbA1C Male hypogonadism is the term used to describe decreased functional activity of the testes with diminished production and action of testosterone. Benign prostatic hyperplasia is a progressive disease defined histologically and characterized by stromal and epithelial cell hyperplasia beginning in the periurethral zone of the prostate.
More NewsEPG Online News
Anti-cholesterol statins linked to blood pressure reduction
16 Apr 2008

Statins prescribed for high cholesterol appear to result in a "modest but significant" reduction in blood pressure, a report claims.

A double-blind placebo-controlled study was carried out on 973 men and women with no known cardiovascular disease or diabetes.

Participants were given either 20 mg of simvastatin, 40 mg of pravastatin or placebo for a period of six months.

Blood pressure readings were taken at the start of the trial and followed up at months one and six, as well as two months after the study's conclusion.

Reductions in both systolic and diastolic blood pressure readings were noted in patients taking both simvastatin and pravastatin.

Researchers have linked the findings with a reduced risk of stroke and cardiovascular events reported by patients taking statins.

"We found that statins lower both systolic and diastolic blood pressure, and that the effect extends to patients with pre-hypertension, those with normal blood pressure and persons not on blood-pressure lowering medications," said lead author Beatrice Golomb from the University of California.

"While reductions in blood pressure with statins were measurable as early as one month into the trial, the lowered blood pressure was significant at six months," she added.

The findings are reported in the April 14th edition of the journal Archives of Internal Medicine.

Click here to learn more about cholesterolADNFCR-1419-ID-18551895-ADNFCR

Print Article    Bookmark Bookmark
Related News Stories (Cholesterol)

FEATURES

DRUG UPDATES Drug updates feed

EMAIL BULLETINS

MEDICAL NEWS EPG News Feed

DISEASE CENTRES Disease Centres feed

RESEARCH

GOOGLE SEARCH

GUIDELINES

DRUG DATA UK Drug Data Feed